Fresenius Medical Care (NYSE: FMS) reported Q1 EPS of $0.75, $0.33 better than the analyst estimate of $0.42. Revenue for the quarter came in at $4.21 billion versus the consensus estimate of $4.25 billion.Fresenius Medical Care reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Fresenius Medical Care (FMS) click here.